NVR CTI (Hydrochlorothiazide and Valsartan 25 mg / 320 mg)

Pill with imprint NVR CTI is Yellow, Elliptical/Oval and has been identified as Hydrochlorothiazide and Valsartan 25 mg / 320 mg. It is supplied by Sandoz Inc.

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 25 mg / 320 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR CTI

Hydrochlorothiazide and valsartan 25 mg / 320 mg NVR CTI

Hydrochlorothiazide and Valsartan

Imprint: NVR CTI
Strength: 25 mg / 320 mg
Color: Yellow
Size: 18.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Angiotensin II inhibitors with thiazides
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Sandoz Inc.
Inactive Ingredients: silicon dioxide, crospovidone, hypromelloses, ferric oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, magnesium silicate, titanium dioxide
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00781-5952	Sandoz Inc.
00078-0472 (Discontinued)	Novartis Pharmaceuticals Corporation
54868-5607 (Discontinued)	Physicians Total Care Inc. (repackager)
35356-0294 (Discontinued)	Lake Erie Medical and Surgical Supply (repackager)